Delivery Order SPE2DB20D3101-SPE2DB23FRVZ7

Award Date 8/28/23
Potential Completion Date 8/29/23
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,893.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humalog 100 Unit/mL KwikPen 3mL, a prescription insulin product. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $1,157.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a prescription insulin medication. There was no...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $1,024.32 firm fixed price delivery order is for the supply of Humalog 100 Unit/mL KwikPen, a brand name injectable insulin product, to support military treatment programs and facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 Unit/mL Kwikpen 3mL insulin pens. The $1,429.09 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc. This single-award IDC with the DLA Troop Support Medical serves as the primary vehicle for...
This federal contract award is for the delivery of Humalog 100 unit/mL KwikPen insulin pens to the Defense Logistics Agency (DLA). The $1,119.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 18, 2022, with a completion date of February 22, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,459.60 firm fixed-price delivery order is for the supply of Humalog 100 Unit/mL KwikPen 3mL, a critical insulin medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This federal contract award, valued at $1,180.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin product. This award is a delivery order made under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and supports the supply of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a diabetes medication. The $1,280.40 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, which runs through November 2026, serves as...
This federal contract award is for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a brand-name insulin medication, to the Defense Logistics Agency (DLA). The $1,025.97 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2022, with a completion date of January 25, 2022. The contract is a delivery order placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award, valued at $1,218.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract covers the delivery of Humalog 100 unit/mL KwikPen 3mL, a pharmaceutical product, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRVZ7
    Delivery Order

This federal contract award, valued at $1,570.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a brand-name insulin product.

The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, as a major pharmaceutical distributor, plays a critical role in supplying essential medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 2/27/25, 11:08 AM